Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

News Focus

Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Post by Metalmindon Oct 23, 2019 10:05am

133 Views

Post# 30258383

Aphria aiming to divest stake in Althea

Oct. 23, 2019 10:02 AM ET |About: Aphria Inc. (APHA)|By: Douglas W. House, SA News Editor

According to the Australian Financial Review, Aphria (APHA -2.1%) is looking to sell the majority of its stake in Melbourne-based Althea despite the favorable evolution of cannabis regulations there and its attractive entry point into Asian markets according to Jefferies' Owen Bennett.

He says that certain pot producers, including Canopy Growth (CGC -0.2%) and Cronos Group (CRON +1.1%) are reducing their exposure to Australia as they clean up their balance sheets, adding that the moves are surprising considering the country's long-term strategic importance.